Phraxis Obtains $1,500,000 New Financing Round

  • Feed Type
  • Date
    12/21/2012
  • Company Name
    Phraxis
  • Mailing Address
    2910 13th Terrace NW St. Paul, MN 55112
  • Company Description
    Phraxis, Inc. is an early stage medical device company founded to develop novel treatment solutions for patients who need vascular access to enable hemodialysis. Phraxis, Inc.’s first product for commercialization, the InterGraft, will be a percutaneously delivered arterio-venous shunt that provides a unique, non-surgical approach for patients who need vascular access.
  • Website
    http://www.phraxis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.